Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
43.01
+3.80 (9.69%)
At close: Jun 6, 2025, 4:00 PM
42.76
-0.25 (-0.58%)
After-hours: Jun 6, 2025, 7:58 PM EDT
Sarepta Therapeutics Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$125.43
Upside
+191.63%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Hold → Buy Upgrades $80 | Hold → Buy | Upgrades | $80 | +86.00% | Jun 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $40 | Hold | Reiterates | $40 | -7.00% | May 22, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $169 → $84 | Buy | Maintains | $169 → $84 | +95.30% | May 20, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $115 → $100 | Buy | Maintains | $115 → $100 | +132.50% | May 8, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $87 → $58 | Hold | Maintains | $87 → $58 | +34.85% | May 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $178 → $100 | Strong Buy | Maintains | $178 → $100 | +132.50% | May 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $112 → $98 | Strong Buy | Maintains | $112 → $98 | +127.85% | May 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $110 → $70 | Buy | Maintains | $110 → $70 | +62.75% | May 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $184 → $123 | Buy | Maintains | $184 → $123 | +185.98% | May 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $163 → $81 | Buy | Maintains | $163 → $81 | +88.33% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $75 → $40 | Hold | Maintains | $75 → $40 | -7.00% | May 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $182 → $113 | Buy | Maintains | $182 → $113 | +162.73% | May 7, 2025 |
| Needham | Needham | Strong Buy Maintains $183 → $125 | Strong Buy | Maintains | $183 → $125 | +190.63% | May 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $182 → $110 | Buy | Maintains | $182 → $110 | +155.75% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $75 | Hold | Reiterates | $75 | +74.38% | Apr 16, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $196 → $182 | Buy | Maintains | $196 → $182 | +323.16% | Apr 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.